Home  »  News   »  FSD Pharma Inc. (HUGE) Vs. Advaxis Inc. (ADXS): Wh...

FSD Pharma Inc. (HUGE) Vs. Advaxis Inc. (ADXS): Which Is Riskier?

FSD Pharma Inc. (NASDAQ: HUGE) shares are -43.82% down in the year-to-date (YTD) period and have moved 7.39% or $0.21 higher in the latest trading session. However, stock’s trailing 12-month performance remains nearly +27.61% lower. Comparatively, the stock is -78.21% down YTD and 2.69% over the trailing 3-month period. If we look at the shorter duration, its week performance is 0.00% and -18.45% over the month.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Analyst Recommendations

0 of the 1 analysts rate the stock as a “Sell”, while 0 has rated it as “Underweight”. 1 recommend buying, with 0 rating it as an Overweight.

The stock currently trades at $3.05. The forecasts give the FSD Pharma Inc. stock a price target range of $8.36 on the higher side while at least one analyst think the stock could plunge to a low of $8.36. The two limits represent an upside potential of 63.52% or 63.52%.

Advaxis Inc. (NASDAQ:ADXS), on the other hand, is trading around $0.48 with a market cap of $30.53M and analyst research firms have a positive stance on its shares. Some analysts are even forecasting $0 per share in earnings this year on a short term (1 year) basis.

Let us briefly look at the Advaxis Inc. (ADXS) financials, with a focus on its operating details as indicated in its earnings report for the last quarter.

Company balance sheet and cash flow

ADXS’s operating expenses over the recent quarter were at -$6.32 million. This represented a 2628.4% of the company’s total revenues which amounted $0.25 million. With this in place, we can see that the company’s diluted EPS declined -$0.10 on the year-over-year period, shrinking to -$1.59 as given in the last earnings report.

In terms of the balance sheet & cash flow as of (Jul 2020), the total assets figure advanced to $45.21 million from $51.35 million over the previous quarter. The cash flow from operating activities totaled -$13.42 million, significantly higher than the -$19.77 million reported in the year-ago quarter. The company’s free cash flow for the quarter was -$13.42 million.

Insider activity

Insiders have transacted a total of 3 times at Advaxis Inc. over the last 6 months, with insider purchases undertaken 0 times and accounting for 0 shares. Insider sales totaled 3,000 shares over the same period, with these deals completed in 3 transactions. Looking at these numbers, we realize that net purchases over that period are -3.0 shares. Insiders now hold a total of 289.56k shares after the latest sales, with -1.00% net shares purchased.

Major holders

Insiders own 0.47% of the company shares, while shares held by institutions stand at 19.70% with a share float percentage of 48.23M. Investors are also buoyed by the number of investors in a company, with Advaxis Inc. having a total of 39 institutions that hold shares in the company.

Related Posts

Hot Penny Stocks to Watch Today

The Covid-19 pandemic has made the biggest impact on blue chips and under $1 stocks (penny stocks), as is typical of the general business environment.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

7 GROWTH STOCKS FOR 2021

Download Free eBook For

100% free. stop anytime no spam